Biotech companies are responding well because they have all the production lines built out to rapidly respond. Academics and other government funded researcher

Biotech companies are responding well because they have all the production lines built out to rapidly respond. Academics and other government funded researchers are responding (personal communication) but they can't do so at the speed of companies who already have their ducks in line. In addition, consider how hard it is for an academic to get regulatory approval. The biotech companies already have relationships with the regulators, while this is completely new ground for those academics, all while the regulators are completely swamped with requests from their preexisting network. Most scientists aren't funded well, but I think a big problem is pouring money into the right holes. Some things will help a lot, some won't. I think getting more investors looking at the system can help with figuring out the right holes to put money into, and that will help just as much as the actual money.